In summary, the candidate probiotic strains with anti-type II diabetes-related activities are currently obtained through in vitro experiments and have a good stimulating effect on GLP-1 secretion in STC-1 cells in this study. The gene discussed is GCG; the disease is type 2 diabetes mellitus.